Cellular response to β‐amyloid neurotoxicity in Alzheimer's disease and implications in new therapeutics

β‐Amyloid (Aβ) is a specific pathological hallmark of Alzheimer's disease (AD). Because of its neurotoxicity, AD patients exhibit multiple brain dysfunctions. Disease‐modifying therapy (DMT) is the central concept in the development of AD therapeutics today, and most DMT drugs that are currentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Haolin, Li, Xianghua, Wang, Xiaoli, Xu, Jiayu, Elefant, Felice, Wang, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Themed Section: Neurodegenerative Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986234/
https://www.ncbi.nlm.nih.gov/pubmed/36872303
http://dx.doi.org/10.1002/ame2.12313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986234/
https://www.ncbi.nlm.nih.gov/pubmed/36872303
http://dx.doi.org/10.1002/ame2.12313

Ejemplares similares